Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
TD Cowen analyst Joshua Buchalter maintains Arteris (NASDAQ:AIP) with a Buy and raises the price target from $15 to $16.5.
Rosenblatt analyst Kevin Cassidy maintains Arteris (NASDAQ:AIP) with a Buy and raises the price target from $14 to $20.
Arteris, Inc. (Nasdaq: AIP), a leading provider of system IP for accelerating semiconductor creation in the AI era, today annou...
Arteris (NASDAQ:AIP) sees Q4 sales of $18.400 million-$18.800 million vs $18.091 million analyst estimate.
Arteris (NASDAQ:AIP) narrows FY2025 sales outlook from $66.000 million-$70.000 million to $68.800 million-$69.200 million vs $6...
Arteris (NASDAQ:AIP) reported quarterly losses of $(0.09) per share which met the analyst consensus estimate. This is a 12.5 pe...
